Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-09-14 Sale | 2021-09-14 7:32 pm | Translate Bio Inc. | TBIO | Renaud Ronald C JR Chief Executive Officer | 954,053 | $38 | $36,254,014 | 0 (Indirect Direct) | View |
| 2021-09-14 Sale | 2021-09-14 7:29 pm | Translate Bio Inc. | TBIO | Burgess Paul D. Chief Operating Officer, CLO | 71,833 | $38 | $2,729,654 | 0 (Direct) | View |
| 2021-09-14 Sale | 2021-09-14 7:26 pm | Translate Bio Inc. | TBIO | Hughes Owen Director | 29,860 | $38 | $1,134,680 | 0 (Direct) | View |
| 2021-09-14 Sale | 2021-09-14 7:23 pm | Translate Bio Inc. | TBIO | FORMELA JEAN FRANCOIS Director | 2,055,063 | $38 | $78,092,394 | 0 (Indirect Direct) | View |
| 2021-09-14 Purchase | 2021-09-14 09:59 am | Translate Bio Inc. | TBIO | Sanofi 10% Owner | 71,983,597 | $38 | $2,735,376,686 | 75,668,031 (Direct) | View |
| 2020-12-21 Sale | 2020-12-23 6:07 pm | Translate Bio Inc. | TBIO | FORMELA JEAN FRANCOIS Director | 139,101 | $25.25 | $3,511,798 | 2,700,459 (Indirect) | View |
| 2020-08-25 Sale | 2020-08-27 8:14 pm | Translate Bio Inc. | TBIO | FORMELA JEAN FRANCOIS Director | 88,888 | $14.83 | $1,318,123 | 3,833,122 (Indirect) | View |
| 2020-06-30 Sale | 2020-06-30 8:24 pm | Translate Bio Inc. | TBIO | Shire Human Genetic Therapies Inc. TAKEDA PHARMACEUTICAL CO LTD 10% Owner | 6,824,992 | $20.68 | $141,140,835 | 0 (Direct) | View |
| 2020-06-26 Purchase | 2020-06-30 5:37 pm | Translate Bio Inc. | TBIO | BAUPOST GROUP LLC Baupost Group GP L.L.C. KLARMAN SETH A 10% Owner | 500,000 | $22 | $11,000,000 | 18,044,239 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-09-14 Other(A) | 2021-09-16 5:43 pm | N/A N/A | Translate Bio Inc. | TBIO | BAUPOST GROUP LLC Baupost Group GP L.L.C. KLARMAN SETH A 10% Owner | 18,044,239 | $38 | 18,044,239 (Indirect) | View |
| 2021-04-07 Exercise(A) | 2021-09-14 7:31 pm | N/A 2027-12-21 | Translate Bio Inc. | TBIO | Renaud Ronald C JR Chief Executive Officer | 9,026 | $0 | 2,025,062 (Direct) | View |
| 2021-04-07 Exercise(A) | 2021-09-14 7:31 pm | N/A N/A | Translate Bio Inc. | TBIO | Renaud Ronald C JR Chief Executive Officer | 9,026 | $7.39 | 2,025,062 (Direct) | View |
Ownership | 2021-08-12 4:00 pm | N/A N/A | Translate Bio Inc. | TBIO | Sanofi See Remarks below | 0 | $0 | 3,684,434 (Direct) | View |
| 2021-06-16 Option Award | 2021-06-17 9:39 pm | N/A 2031-06-15 | Translate Bio Inc. | TBIO | FORMELA JEAN FRANCOIS Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-06-16 Option Award | 2021-06-16 5:18 pm | N/A 2031-06-15 | Translate Bio Inc. | TBIO | Beckman Daniella Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-06-16 Option Award | 2021-06-16 5:16 pm | N/A 2031-06-15 | Translate Bio Inc. | TBIO | Plenge Robert M Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-06-16 Option Award | 2021-06-16 5:15 pm | N/A 2031-06-15 | Translate Bio Inc. | TBIO | Meyer Robert J. Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-06-16 Option Award | 2021-06-16 5:14 pm | N/A 2031-06-15 | Translate Bio Inc. | TBIO | Hughes Owen Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-06-16 Option Award | 2021-06-16 5:13 pm | N/A 2031-06-15 | Translate Bio Inc. | TBIO | Demetri George Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-04-19 Option Award | 2021-04-20 4:49 pm | N/A 2031-04-18 | Translate Bio Inc. | TBIO | Smith Brendan Chief Financial Officer | 201,800 | $0 | 201,800 (Direct) | View |
| 2021-04-07 Exercise | 2021-04-09 4:14 pm | N/A 2027-12-21 | Translate Bio Inc. | TBIO | Renaud Ronald C JR Chief Executive Officer | 9,026 | $0 | 2,025,152 (Direct) | View |
| 2021-04-07 Exercise | 2021-04-09 4:14 pm | N/A N/A | Translate Bio Inc. | TBIO | Renaud Ronald C JR Chief Executive Officer | 9,026 | $7.39 | 2,025,152 (Direct) | View |
| 2021-03-22 Option Award | 2021-03-23 4:40 pm | N/A 2031-03-22 | Translate Bio Inc. | TBIO | Sutherland Everett Rand President | 300,000 | $0 | 300,000 (Direct) | View |
| 2021-03-09 Option Award | 2021-03-09 8:27 pm | N/A 2031-03-09 | Translate Bio Inc. | TBIO | Renaud Ronald C JR Chief Executive Officer, Pres. | 325,000 | $0 | 325,000 (Direct) | View |
| 2021-03-09 Option Award | 2021-03-09 8:26 pm | N/A 2031-03-09 | Translate Bio Inc. | TBIO | Wooster Richard Chief Scientific Officer | 70,000 | $0 | 70,000 (Direct) | View |
| 2021-03-09 Option Award | 2021-03-09 8:24 pm | N/A 2031-03-09 | Translate Bio Inc. | TBIO | Barbier Ann Chief Medical Officer | 70,000 | $0 | 70,000 (Direct) | View |
| 2021-03-09 Option Award | 2021-03-09 8:23 pm | N/A 2031-03-09 | Translate Bio Inc. | TBIO | Burgess Paul D. Chief Operating Officer, CLO | 90,000 | $0 | 90,000 (Direct) | View |
| 2020-12-17 Ownership | 2021-02-16 4:12 pm | N/A N/A | Translate Bio Inc. | TBIO | LYNCH DANIEL Director | 100,000 | $0 | 221,825 (Direct) | View |
| 2021-01-14 Exercise | 2021-01-14 7:59 pm | N/A N/A | Translate Bio Inc. | TBIO | Renaud Ronald C JR Chief Executive Officer, Pres. | 1 | $8.34 | 2,115,058 (Direct) | View |
| 2021-01-14 Exercise | 2021-01-14 7:59 pm | N/A 2027-12-21 | Translate Bio Inc. | TBIO | Renaud Ronald C JR Chief Executive Officer, Pres. | 5,639 | $0 | 2,115,058 (Direct) | View |
| 2021-01-14 Exercise | 2021-01-14 7:59 pm | N/A N/A | Translate Bio Inc. | TBIO | Renaud Ronald C JR Chief Executive Officer, Pres. | 5,638 | $7.39 | 2,115,058 (Direct) | View |
| 2020-11-16 Exercise | 2020-11-18 7:30 pm | N/A N/A | Translate Bio Inc. | TBIO | Renaud Ronald C JR Chief Executive Officer, Pres. | 3 | $8.34 | 2,115,058 (Direct) | View |
| 2020-11-16 Exercise | 2020-11-18 7:30 pm | N/A 2027-12-21 | Translate Bio Inc. | TBIO | Renaud Ronald C JR Chief Executive Officer, Pres. | 53,007 | $0 | 2,115,058 (Direct) | View |
| 2020-11-16 Exercise | 2020-11-18 7:30 pm | N/A N/A | Translate Bio Inc. | TBIO | Renaud Ronald C JR Chief Executive Officer, Pres. | 53,004 | $7.39 | 2,115,058 (Direct) | View |
| 2020-06-16 Option Award | 2020-06-17 5:52 pm | N/A 2030-06-15 | Translate Bio Inc. | TBIO | LYNCH DANIEL Director | 18,900 | $0 | 18,900 (Direct) | View |
| 2020-06-16 Option Award | 2020-06-17 5:51 pm | N/A 2030-06-15 | Translate Bio Inc. | TBIO | Beckman Daniella Director | 18,900 | $0 | 18,900 (Direct) | View |
| 2020-06-16 Option Award | 2020-06-17 5:49 pm | N/A 2030-06-15 | Translate Bio Inc. | TBIO | FORMELA JEAN FRANCOIS Director | 18,900 | $0 | 18,900 (Direct) | View |